Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceSEVEN CONTINUOUS GLUCOSE MONITORING SYSTEMS
Generic NameSensor, glucose, invasive
ApplicantDEXCOM, INC.
5555 OBERLIN DR
SAN DIEGO, CA 92121
PMA NumberP050012
Supplement NumberS011
Date Received06/05/2007
Decision Date11/13/2007
Withdrawal Date 08/28/2015
Product Code MDS 
Advisory Committee Clinical Chemistry
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL FOR CALIBRATION OF THE DEXCOM SEVEN CONTINUOUS GLUCOSE MONITORING SYSTEM USING ANY FDA CLEARED BLOOD GLUCOSE METER.
-
-